Stratum Biosciences Raises $2M Seed Funding for AI Skin Discovery

Stratum Biosciences, a biotechnology firm focused on AI and dermatology, has successfully closed a $2 million seed funding round. The capital infusion will accelerate the company's AI-powered research into skin biology and expand its research and development partnerships. This funding positions Stratum to advance its innovative approaches in dermatological discovery, leveraging artificial intelligence to uncover new insights and potential treatments. The investment underscores growing confidence in the intersection of AI and biotech for medical advancements.